Hydrophilic loop 1 of Presenilin-1 and the APP GxxxG transmembrane motif regulate γ-secretase function in generating Alzheimer-causing Aβ peptides

[1]  Yigong Shi,et al.  Structural basis of γ-secretase inhibition and modulation by small molecule drugs , 2020, Cell.

[2]  Douglas R Martin,et al.  A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  T. Tomita,et al.  Conformational Dynamics of Transmembrane Domain 3 of Presenilin 1 Is Associated with the Trimming Activity of γ-Secretase , 2019, The Journal of Neuroscience.

[4]  Yigong Shi,et al.  Recognition of the amyloid precursor protein by human γ-secretase , 2019, Science.

[5]  D. Selkoe,et al.  A cellular complex of BACE1 and γ-secretase sequentially generates Aβ from its full-length precursor , 2019, The Journal of cell biology.

[6]  Krishanu Saha,et al.  CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage , 2019, Nature Communications.

[7]  E. Futai,et al.  Specific mutations in presenilin 1 cause conformational changes in &ggr;-secretase to modulate amyloid &bgr; trimming , 2018, Journal of biochemistry.

[8]  D. Borchelt,et al.  Short Aβ peptides attenuate Aβ42 toxicity in vivo , 2018, The Journal of experimental medicine.

[9]  T. Tomita,et al.  Activation of γ-Secretase Trimming Activity by Topological Changes of Transmembrane Domain 1 of Presenilin 1 , 2017, The Journal of Neuroscience.

[10]  P. S. St George-Hyslop,et al.  Structural and Chemical Biology of Presenilin Complexes. , 2017, Cold Spring Harbor perspectives in medicine.

[11]  Y. Ihara,et al.  Alanine substitutions in the GXXXG motif alter C99 cleavage by γ‐secretase but not its dimerization , 2017, Journal of neurochemistry.

[12]  Yigong Shi,et al.  Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase , 2016, Proceedings of the National Academy of Sciences.

[13]  D. Selkoe,et al.  The amyloid-beta forming tripeptide cleavage mechanism of γ-secretase , 2016, eLife.

[14]  T. Iwatsubo,et al.  Conformational Changes in Transmembrane Domain 4 of Presenilin 1 Are Associated with Altered Amyloid-β 42 Production , 2016, The Journal of Neuroscience.

[15]  Guanghui Yang,et al.  Sampling the conformational space of the catalytic subunit of human γ-secretase , 2015, bioRxiv.

[16]  Sjors H. W. Scheres,et al.  An atomic structure of human γ-secretase , 2015, Nature.

[17]  T. Iwatsubo,et al.  Cooperative Roles of Hydrophilic Loop 1 and the C-Terminus of Presenilin 1 in the Substrate-Gating Mechanism of γ-Secretase , 2015, The Journal of Neuroscience.

[18]  Takeshi Iwatsubo,et al.  Allosteric regulation of γ-secretase activity by a phenylimidazole-type γ-secretase modulator , 2014, Proceedings of the National Academy of Sciences.

[19]  Yanyu Zhao,et al.  Three-dimensional structure of human γ-secretase , 2014, Nature.

[20]  R. Tanzi,et al.  Soluble γ-Secretase Modulators Selectively Inhibit the Production of the 42-Amino Acid Amyloid β Peptide Variant and Augment the Production of Multiple Carboxy-Truncated Amyloid β Species , 2014, Biochemistry.

[21]  Douglas S. Johnson,et al.  Development and mechanism of γ-secretase modulators for Alzheimer's disease. , 2013, Biochemistry.

[22]  C. Haass,et al.  Important functional role of residue x of the presenilin GxGD protease active site motif for APP substrate cleavage specificity and substrate selectivity of γ‐secretase , 2013, Journal of neurochemistry.

[23]  M. Takeda,et al.  γ-secretase modulators and presenilin 1 mutants act differently on presenilin/γ-secretase function to cleave Aβ42 and Aβ43. , 2013, Cell reports.

[24]  Ole A. Andreassen,et al.  A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.

[25]  T. Iwatsubo,et al.  Phenylpiperidine‐type γ‐secretase modulators target the transmembrane domain 1 of presenilin 1 , 2011, The EMBO journal.

[26]  Richard M. Page,et al.  Attenuated Aβ42 Responses to Low Potency γ-Secretase Modulators Can Be Overcome for Many Pathogenic Presenilin Mutants by Second-generation Compounds* , 2011, The Journal of Biological Chemistry.

[27]  R. Vassar,et al.  Molecular Neurodegeneration BioMed Central Review The Alzheimer's disease β-secretase enzyme, BACE1 , 2007 .

[28]  Dieter Langosch,et al.  GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Aβ42 , 2007 .

[29]  T. Kudo,et al.  Presenilins mediate a dual intramembranous γ‐secretase cleavage of Notch‐1 , 2002 .

[30]  Huaxi Xu,et al.  Presenilin 1 Is Required for Maturation and Cell Surface Accumulation of Nicastrin* , 2002, The Journal of Biological Chemistry.

[31]  Rong Wang,et al.  A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity , 2001, Nature.

[32]  H. Struyfs,et al.  Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis. , 2015, Journal of Alzheimer's disease : JAD.

[33]  D. Holtzman,et al.  Deciphering Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[34]  B. de Strooper,et al.  Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease. , 2012, Cold Spring Harbor perspectives in medicine.

[35]  D. Kovacs,et al.  The many substrates of presenilin/γ-secretase. , 2011, Journal of Alzheimer's disease : JAD.